LifeCannMD

MAY 11, 2022

So how has it come to be that Florida physicians are able to give patients that qualify a “recommendation” for Medical Marijuana? . Two years later, in 2016, State Bill 307 opened up access to full-strength MMJ to patients who were determined by two separate doctors to be terminally ill and have less than a year to live.

Law 52

Law Marijuana Patients Epilepsy 52

The Joint Blog

JANUARY 20, 2021

In many cases, a marijuana supply is not used to actually treat health problems directly and cannabis can’t cure diseases on its own, but it can be an essential and powerful complementary treatment to alleviate a patient’s suffering. Vlad Hughes is a business development manager and digital marketer at CannabizSupply.

Marijuana 68

Marijuana Sleep Chronic Pain Research and Development 68

MMJ Recs

APRIL 11, 2024

West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. It aims to provide regulated and secure avenues for patients to obtain medical marijuana while ensuring adherence to stringent state laws and regulations.

Law 52

Law Programs Patients Conditions 52

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

FEBRUARY 17, 2020

I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

JANUARY 24, 2020

Currently very limited in its nature, MCAP is only open to patients with spasticity associated with multiple sclerosis and intractable nausea and vomiting associated with chemotherapy that doesn’t respond to conventional treatments. Additionally, severe refractory (treatment-resistant) epilepsy also qualifies.

Oil 45

Oil Epilepsy Conditions Treatment 45

Peninsula Alternative Health

FEBRUARY 22, 2018

As medical cannabis professionals, our PAH staff makes suggestions with the patient understanding that it’s entirely up to you to identify your medication “sweet spot” in order to treat your qualifying condition. Below the product name is the amount (usually in grams) within the package, such as a 3.5-gram gram package.

Terpenes 40

Terpenes Trichome Strains Cannabinoids 40

Marijuana Packaging

FEBRUARY 27, 2018

A CBD dose can be difficult to determine though we provided a CBD dosage guide “People are using this as medicine for many conditions (anxiety, inflammation, pain, epilepsy)," said one of the study's authors Marcel Bonn-Miller. The result is patients not being treated for their illness in an accurate and trustworthy way.

Extraction 52

Extraction CBD Marijuana Oil 52

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 98

Research and Development Oil Cannabis Clinical Trials 98

Cannabis Law Report

MAY 26, 2019

They didn’t know they’d confront epilepsy head on, since none of their family before them had been exposed to it. They’ve learned the importance of packaging and sourcing and dived deep into understanding test results. PACKAGING MATTERS A GREAT DEAL TO THE CONSUMER. “ But he did it. .

Strains 56

Strains Wellness and Beauty Education Research and Development 56

SMPL

FEBRUARY 20, 2020

The legislation would allow patients with qualifying conditions to purchase cannabis products from licensed dispensaries. It would be a limited system, however, prohibiting patients from smoking or vaping marijuana. The legislation would allow patients with qualifying conditions to purchase cannabis products from licensed dispensaries.

Legalization 40

Legalization Marijuana Seed-To-Sale Legislation 40

Cannabis Law Report

SEPTEMBER 21, 2021

For example, it relieves chronic pain, and the product is common for arthritis and cancer patients. CBD oil also controls seizures in epilepsy patients. The last stage is lab testing and packaging. Other uses are to reduce stress and kill insomnia, and it also acts as an antidepressant.

Oil 52

Oil CBD Extraction Hemp 52

Marijuana Packaging

SEPTEMBER 23, 2024

Epidiolex is an orally administered medication designed to treat certain types of epilepsy in patients age 2-years and older. Of course, the genuine article is probably a safer bet, but for patients in the hold-out states that have yet to legalize medical use cannabis, this may be the closest they get to relief for the time being.

History 40

History Programs Epilepsy Patients 40

Marijuana Lawyer Blog

SEPTEMBER 14, 2018

How do we make the packaging child safe? Food & Drug Administration is one designed specifically for children with severe forms of epilepsy. The Los Angeles CANNABIS LAW Group represents growers, dispensaries, collectives, patients, defendants, workers and those facing criminal marijuana charges. Call us at 714-937-2050.

Marijuana 40

Marijuana Dispensary Medicine Safety 40

Marijuana Packaging

NOVEMBER 2, 2018

Epidiolex is an orally administered medication designed to treat certain types of epilepsy in patients age 2-years and older. Of course, the genuine article is probably a safer bet, but for patients in the hold-out states that have yet to legalize medical use cannabis, this may be the closest they get to relief for the time being.

History 40

History Programs Epilepsy Patients 40

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 10, 2021

“We are encouraged with the progress that has been made under the CRADA with NCATS and the NIH Helping to End Addiction Long-term (HEAL) initiative, as we believe that it may help Virpax develop an effective and safe alternative to conventional opioids used by patients to manage acute and chronic pain. Forward-Looking Statement.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

The Cannigma

APRIL 7, 2022

Their beautiful packaging and marketing will put a link in the show notes. I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. CP: See when it was packaged. CP: Okay, everyone.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

Cannabis Law Report

NOVEMBER 15, 2021

We are looking forward to the completion of the required IND enabling studies and submitting our IND package to the FDA in anticipation of first-in-human trials,” continued Mr. Mack. for its MET for the nasal delivery of cannabidiol (CBD) for the management of epilepsy in children (rare pediatric disease) and adults.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

The Cannigma

FEBRUARY 21, 2021

Really large European ag-techs, really large North American CPG (consumer packaged goods) companies, Big Tobacco — they’re ready to make moves. They are making those moves,” said Jake Kuczeruk, vice president of business development at The Arcview Group, a cannabis investment, consulting, and research group. “You Is wellness the future?

Research and Development 143

Research and Development Pharmaceutical Recreational Cannabis 143

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Canna Law Blog

APRIL 27, 2020

and its ability to suppress pain and aid in the detoxification processes has highlighted it as a promising therapeutic for a wide array of disorders such as epilepsy, including many challenging neuropathy conditions. One delivery option is BIOTA CBD Sterile Vial Therapy.

CBD 89

CBD Topical Oil Treatment 89

Cannabis Law Report

DECEMBER 18, 2019

Notably, the increase comes after the company recently broke into the European pharma-market after getting green-lighted from the Irish Government to sell its phytocannabinoid-derived “CannEpil” product to epilepsy sufferers. Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

APRIL 10, 2019

My sympathies go out to the patients and their families who are desperately seeking to alleviate their symptoms with medicinal cannabis. Indeed, prescriptions have been written for the products that the family attempted to bring into the country and these have been supplied to patients. I know just how frustrated they are.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Veriheal

FEBRUARY 11, 2025

Kentucky residents have been waiting patiently to have access to medical marijuana. This long-anticipated development marks a major shift in Kentuckys stance on cannabis, opening new doors for patients seeking alternative treatments. As of January 1, 2025, the long-awaited official launch of Kentuckys medical cannabis program occurred.

Marijuana 59

Marijuana Dispensary Programs Patients 59

Cannabis Law Report

DECEMBER 30, 2019

Since 2014, annual appropriations bills have been amended to include a spending restriction to prevent the Department of Justice from enforcing the federal prohibition of marijuana against state-legal medical cannabis programs, businesses, and patients. Included in the final FY 2020 spending package). A Pathway Towards SAFE Banking.

Legislation 45

Legislation Patients Access Banking 45

Otherside Farms

MAY 5, 2020

Epilepsy and Seizures. It’s not uncommon for a dog to get diagnosed with epilepsy. There have been studies done on epilepsy patients using CBD and over 80% of them reported that CBD significantly reduced their seizures. Also, it is good to keep an eye out for QR codes on a CBD product’s packaging.

CBD 52

CBD Pets Research and Development Epilepsy 52

SpeedWeed

MAY 10, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Recreational 52

Recreational Marijuana Legislation Seed-To-Sale 52

SpeedWeed

MAY 8, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 7, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 7, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 19, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 18, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

THC 52

THC Legislation Seed-To-Sale Patients 52

SpeedWeed

MAY 17, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 17, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 10, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 40

Legislation Seed-To-Sale Patients Chronic Pain 40